Poll: docs say don't take away CME support

Share this article:
A poll of 268 physicians found that 92% disagree with an American Medical Association (AMA) committee's call to end commercial support of CME.

Respondents to the online poll, by med ed provider Pri-Med, expressed concern that a ban on commercial support would make it more expensive for them to receive CME and that the quality of CME would decrease, making it harder for physicians to stay up to date and ultimately impacting patient care.
“I don't receive CME reimbursement from my employer,” said one respondent. “Any subsidy is very beneficial to me.”

Last month, the AMA's Council on Ethical and Judicial Affairs, which makes ethics policy for the society, issued a report arguing that physicians and institutions of medicine should not accept commercial support for CME except for narrow technical training on new diagnostic or therapeutic devices and techniques. The report's recommendations will be taken up by the AMA House of Delegates at its annual meeting, June 14-18 in Chicago.
Share this article:

Email Newsletters

More in News

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...

FDA kind of OKs Lilly/BI's Lantus look-alike

FDA kind of OKs Lilly/BI's Lantus look-alike

Sanofi's patent lawsuit triggered the tentative approval of the Lilly-BI Lantus competitor.

GSK relaunches COPD.com

GSK relaunches COPD.com

The refresh launched soon after the company encouraged investors to take a long view of GSK as the firm posted weak respiratory numbers.